Navigation Links
With Peripheral Artery Disease, Med Adherence Is Low
Date:4/24/2009

Survival, though, is greater when guidelines are followed, study finds

FRIDAY, April 24 (HealthDay News) -- Less than half of those who have peripheral artery disease are taking the recommended combination of medications to control it, new research says.

Researchers collected data on 711 people with peripheral artery disease who had vascular surgery at 11 hospitals in the Netherlands in 2004. Three years later, 465 of the surviving 552 patients answered a questionnaire about their medication use.

About half were taking the guideline-recommended medical therapy, a combination of aspirin and statins in all patients and beta blockers in those who also had ischemic heart disease, said study author Dr. Don Poldermans, of the Erasmus Medical Center in Rotterdam.

Those who were taking the recommended medications had a better chance of being alive three years after their surgery, the study found.

Researchers also found that after three years, aspirin was being taken by 74 percent, statins by 69 percent and beta blockers by 54 percent.

"Guideline-recommended medical therapy use for the combination of aspirin, statins and beta blockers ... was lower than expected," the authors said in a news release from the American Heart Association. "These data clearly indicate the need for initiating optimal medical treatment at the preoperative outpatient clinic, as well as improvement of long-term medication use."

Their research was to be presented Friday at the American Heart Association's 10th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke in Washington, D.C. and will be published in Circulation: Cardiovascular Outcomes and Quality.

Peripheral artery disease is a circulatory problem in which narrowed arteries reduce blood flow to the limbs. Symptoms typically include leg pain when walking.

The disease is also often a sign of athe
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
2. Riverside First to Offer New Treatment for Peripheral Arterial Disease
3. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
4. Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
5. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
6. American College of Physicians publishes "Peripheral Arterial Disease"
7. Peripheral Artery Disease Up Sharply Among U.S. Women
8. Asymptomatic peripheral artery disease prevalence is rising
9. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
10. Peripheral Arterial Disease Costlier to Treat Than Heart Trouble
11. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
With Peripheral Artery Disease, Med Adherence Is Low
With Peripheral Artery Disease, Med Adherence Is Low
(Date:12/16/2009)... from around the world have visited Israel,s Dead Sea ... reputation that dates back over 2000 years, and legend ... introduction of two bath salt lines from SaltWorks ( ... Dead Sea salt in their own homes. ,, SaltWorks, ... and essential oils - but no artificial colors or ...
(Date:12/16/2009)... BOCA RATON, Fla., Dec. 16 Dale Buchanan, owner ... has decided to have a weight loss contest for his ... is that the students are not competing for their own ... to raise money for the Tri County Humane Society ... each student of mine loses between January 4 and February ...
(Date:12/16/2009)... care, but privacy a concern, doctors say , , ... support the use of electronic medical records, but ... studies show. , One study of more than ... found that 86 percent believed electronic health information ... 70 percent thought it would reduce costs and ...
(Date:12/16/2009)... County area dry cleaner Dryclean USA donates time and money to ... ... (PRWEB) Dec. 16, 2009 -- South Florida dry cleaner Dryclean ... with the charity Prints of Hope to help clothe ... needy families. Dryclean USA Florida will begin distributing cards, with ...
(Date:12/16/2009)... CITY, Dec. 16 /PRNewswire-FirstCall/ - TSO3 Inc. ("TSO3") ... an agreement has been reached for 3M to ... STERIZONE(R) 125L+ Sterilizer. The partnership with TSO3, an ... devices in healthcare settings through the use of ... care facilities through 3M,s global sales channel. This ...
Breaking Medicine News(10 mins):Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:Pros and Cons of Electronic Medical Records Weighed 2Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 2Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 3Health News:TSO3 and 3M agree to global channel partnership - 3M to begin rollout in sequential markets as regulatory clearances are received 4
... Global Consensus and New Partnerships Sought to Improve Health Systems in ... ... Accelerating innovative applications,of emerging digital technologies to improve the health of ... eHealth -- will be,the main topic of a major international conference ...
... (BioMedical Enterprises, Inc.),a privately held medical device company and ... launch of the OSSAnchor(TM),Grip, a nitinol implant designed to ... the first in the family of OSSAnchor(TM) nitinol soft,tissue ... Grip is a,nitinol implant with aggressive barbs on the ...
... PRINCETON, N.J., June 2 The New Jersey,Hospital ... as its,general counsel, NJHA,s president-designee Betsy Ryan announced., ... Counsel Karen Ali,who has been named NJHA,s vice ... counsel, Jacobs will provide direction on all legal ...
... CONCORD, MASS., June 2, 2008 As America,s baby ... years of age and older is expected to double ... decline and incidence of chronic conditions, including Alzheimer,s, heart ... supports that good nutrition particularly a diet including ...
... The Walk on the Capitol,is proud to announce ... as special guest speaker for our National obesity awareness ... on the Capitol is a,history-making awareness event that will ... attention to the obesity epidemic and,the need for expanded ...
... to Protect and Even Improve Health, MADISON, Wis., ... contaminated and polluted, and now studies have linked poor,indoor ... allergy and asthma,symptoms but also a variety of other ... Studies are emerging that prove poor indoor air quality ...
Other Medicine News:Health News:Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 2Health News:Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 3Health News:Innovative Uses of Technology to Improve Health for Poor and Vulnerable People to be Explored at Rockefeller Foundation Conference 4Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor 2Health News:Drinking polyphenol-rich Concord grape juice may improve memory in older adults 2Health News:Television Star Caitlin Van Zandt Signs-on as Special Guest Speaker for National Obesity Awareness Event in Washington, DC, on June 17 2Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 2Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 3
(Date:12/16/2009)... Today, Avantium announced the,appointment of ... its pharmaceutical,business. Gunnar Staaf previously worked at ... & Company, in a range of commercial ... step in Avantium,s plan to,spin-out its pharmaceutical ... pharmaceutical company based on its offering of ...
(Date:12/16/2009)... CORALVILLE, Iowa, Dec. 16 Vivakor, ... a Business Development agreement with Baker Consulting ... affiliate group, Kyouko Group, Inc. out of ... retained by Vivakor to assist with business ... its recently reported acquisition strategy. Specifically, Baker ...
(Date:12/16/2009)... 16 Naurex Inc., a new clinical ... other CNS disorders based on its novel GFPA ... at a major medical meeting showed that its ... activity with no signs of the CNS-related side ... receptor(1). The studies also showed that GLYX-13,s ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Plastic surgeons should be part of disaster relief planning response 56802 1Plastic surgeons should be part of disaster relief planning response 56802 2Plastic surgeons should be part of disaster relief planning response 56802 3SNM applauds FDAs decision to approve Zevalin 56799 1SNM applauds FDAs decision to approve Zevalin 56799 2UTSA Physics Department receives 242 7 million to study nanomaterials 9872 1UTSA Physics Department receives 242 7 million to study nanomaterials 9872 2
... /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext ... identifies, develops and commercializes differentiated products for ... entitled, "Binding properties of the anti-EGFR monoclonal ... in renal and epidermal cells", has been ...
... Presented at USCAP MeetingSOUTH SAN FRANCISCO, Calif., March 13 ... today announced the enrollment of the first patient in ... disodium) in patients with refractory or relapsed peripheral T-cell ... to assess the efficacy of R788, an orally bio-available ...
Other Medicine Technology:YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 3YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 5Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas 2Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas 3
... The Ulti-Mist™ HME product line has the ... pediatrics to adults and from intubated patients ... superior humidification for both anesthesia and critical ... HME/Filters provide maximum protection for patients and ...
... HME product line has the right product ... adults and from intubated patients to patients ... for both anesthesia and critical care applications., ... maximum protection for patients and staff members. ...
... condenser humidifiers (HCH) capture the patient`s exhaled ... the inspired gas. Small and compact, they ... hygroscopic benefits. Depending on the tidal volume ... model., ,The adult HCH is ideal ...
... condenser humidifiers (HCH) capture the patient`s exhaled ... the inspired gas. Small and compact, they ... hygroscopic benefits. Depending on the tidal volume ... model., ,The adult HCH is ideal ...
Medicine Products: